Results 281 to 290 of about 844,715 (299)

Regiospecific synthesis of alfa-diones, alfa,alfa-dialkoxyketones and alfa-alkoxy-alfa-sulfenylated ketones

2000
Abbaspour Tehrani, Kourosch, Boeykens, Mark, Tyvorskii, Vladimir I., Kulinkovich, Oleg G., De Kimpe, Norbert   +4 more
openaire   +1 more source

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Lancet, The, 2010
Paul Y Kwo, Mitchell N Davis, Stuart C Gordon   +2 more
exaly  

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

Lancet, The, 2000
Stephan N Wagner, Vera Rebmann
exaly  

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

Lancet, The, 2009
Perry M Elliott, Roberto Giugliani, Ales Linhart   +2 more
exaly  

Alglucosidase-alfa/avalglucosidase-alfa

Reactions Weekly
openaire   +1 more source

Peginterferon-alfa-2a/peginterferon-alfa-2b/ribavirin

Reactions Weekly, 2023
openaire   +1 more source

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

Lancet, The, 2001
exaly  

Velaglucerase alfa

Nature Reviews Drug Discovery, 2010
Peter Kirkpatrick, Johannes Aerts
exaly  

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

Lancet, The, 2007
Simon Nadel, Mark John Peters
exaly  

Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks' gestation: a randomised trial

Lancet, The, 2000
Michael W Beresford, John N S Matthews, Martin P Ward Platt   +2 more
exaly